Risk | High |
---|---|
Min SIP Amount | Not Supported |
Expense Ratio | 1.36% |
NAV | ₹14.10 (25 Jan 2021) |
---|---|
Fund Started | 27 Jun 2018 |
Fund Size | ₹299 Cr |
Name | Sector | Instrument | % Assets |
---|---|---|---|
Deepak Nitrite Ltd. | Chemicals | Equity | 7.0% |
Suven Pharmaceutical Ltd. | Healthcare | Equity | 4.9% |
Navin Fluorine International Ltd. | Chemicals | Equity | 4.4% |
Kajaria Ceramics Ltd. | Construction | Equity | 3.9% |
Neogen Chemicals Ltd. | Chemicals | Equity | 3.7% |
Persistent Systems Ltd. | Technology | Equity | 3.1% |
Multi Commodity Exchange India | Financial | Equity | 3.1% |
Zydus Wellness Ltd. | FMCG | Equity | 3.0% |
Kei Industries Ltd. | Engineering | Equity | 2.9% |
Aarti Industries Ltd. | Chemicals | Equity | 2.9% |
L&T Emerging Opportunities Fund Series II Regular Dividend is a Equity Mutual Fund Scheme launched by L&T Mutual Fund. This scheme was made available to investors on 27 Jun 2018. Vihang Naik is the Current Fund Manager of L&T Emerging Opportunities Fund Series II Regular Dividend fund.The fund currently has an Asset Under Management(AUM) of ₹299 Cr and the Latest NAV as of 25 Jan 2021 is ₹14.10.
The L&T Emerging Opportunities Fund Series II Regular Dividend is rated High risk. Minimum SIP Investment is set to 500.
The scheme seeks to provide capital appreciation by primarily investing in equity and equity related instruments of small cap companies